(C) Daily Kos
This story was originally published by Daily Kos and is unaltered.
. . . . . . . . . .



Diabetes News Survey [1]

['This Content Is Not Subject To Review Daily Kos Staff Prior To Publication.']

Date: 2025-06-04

These posts are generally about a specific advance in diabetes treatment, but today I am instead giving you a roundup of a variety of recent news. Each of these stories is important, but I can’t do them all justice treating them one a week. So instead I will just bring them to your attention, and let you dive into the links to whatever is most important to you. Let us know what that is, please. I would also be pleased if someone else stepped up to write on such topics for this group.

Note that all of these notes come from my Diabetes list on Bluesky, which is becoming a better and better source of all kinds of information all the time. It is also attracting more and more influencers, and refugees from Facebook, Twitter, and elsewhere, and in general moving from strength to strength.

x Diabetes is a leading global health and economic challenge, affecting over 800 million people worldwide, with over 80% residing in low-income and middle-income countries (LMICs) www.thelancet.com/journals/lan... #diabetes

#FREE to read with registration (also FREE) #MedSky #EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 27, 2025 at 5:36 AM

x The Copenhagen Declaration sets a bold vision for transforming #diabetes care and research globally and offers a set of metrics for measuring progress www.thelancet.com/journals/lan...

#FREE to read with registration (also FREE) #MedSky #EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 23, 2025 at 5:55 PM

x Edited by professor emeritus and founding director Jeff Bluestone, and featuring @mandersonucsf.bsky.social @bhushanlab.bsky.social, Qizhi Tang, Mike German, and Zoe Quandt, advances in understanding and treatment 100 years after insulin, from Cold Spring Harbor tinyurl.com/56mhp7t2



[image or embed] — UCSF Diabetes Center (@ucsfdc.bsky.social) May 20, 2025 at 4:15 PM

x Weight loss of 10–15% by any means soon after onset of type 2 #diabetes is highly likely to bring about #remission of diabetes www.thelancet.com/journals/lan...

#weightloss #T2D #MedSky #EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 10, 2025 at 5:10 AM

x People with #diabetes often encounter #stigma (ie, negative social judgments, stereotypes, prejudice), which can adversely affect emotional, mental, & physical health; self-care, access to optimal health care; & social and professional opportunities tinyurl.com/4tps2re6

#FREE to read w/reg

#EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 9, 2025 at 12:31 PM

x Current evidence for effective and safe means of preventing type 2 #diabetes in the long term supports lifestyle intervention, emphasising weight loss and moderate physical activity at any adult age, and metformin in younger adults www.thelancet.com/journals/lan...

#T2D #prevention

#MedSky #EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 3, 2025 at 7:48 AM

x Children born to mothers with #diabetes are at risk of #neurodevelopmental disorders, with higher risks observed for pre-gestational diabetes compared with #gestational diabetes www.thelancet.com/journals/lan...

#T1D #T2D #GDM #neurodevelopment #MedSky #EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 15, 2025 at 2:55 AM

x Mitigating the risk of antimicrobial resistance in people with #diabetes requires a comprehensive approach, combining prevention, diagnosis, treatment, and research www.thelancet.com/journals/lan...

#FREE to read with registration (also FREE) #MedSky #EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 23, 2025 at 6:02 PM

This next study is hot stuff. Now tell us how AID can help with T2D. I would be happy to have such an implant if it meant no more shots and better control. With FDA approval and Medicare coverage, of course, and whatever assistance others need.

x Automated insulin delivery (AID) systems improve blood glucose control in type 1 #diabetes, as is shown in a current study. The meta-analysis, which evaluated 46 clinical studies with 4,113 participants, is the most comprehensive study of its kind. #Diabetes #Insulin

➡️https://t1p.de/uh2fq



[image or embed] — Deutsches Zentrum für Diabetesforschung (DZD) (@diabresearch-dzd.bsky.social) May 14, 2025 at 3:13 AM

x Glycaemic management strategies for #olderadults with type 1 and type 2 #diabetes not responding to their current regimen require an understanding of how and when to realign therapy to meet patient's current needs www.thelancet.com/journals/lan... #T1D #T2D

#FREE to read w/reg (also FREE)

#EndoSky



[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) May 30, 2025 at 11:30 AM

I can’t take metformin. It gives me horrendous diarrhea. I’m happy for those who can.

[END]
---
[1] Url: https://dailykos.com/stories/2025/6/4/2325862/-Diabetes-News-Survey?pm_campaign=front_page&pm_source=latest_community&pm_medium=web

Published and (C) by Daily Kos
Content appears here under this condition or license: Site content may be used for any purpose without permission unless otherwise specified.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/dailykos/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.